Results demonstrated consistent weight loss across all four studies, with nearly 70% of participants achieving at least 5% body weight reduction and approximately 35% reaching 15% or greater weight loss
and the number of fatal or nonfatal strokes, including hemorrhagic stroke, ischemic stroke, or transient ischemic attack (TIA) was reported
PlexusDx does not work with 503B outsourcing facilities, eliminating exposure to the regulatory concerns the FDA has flagged regarding bulk semaglutide production
On the other hand, when injected into the body, specifically in the abdomen, GLP-1 can remain effective for up to 24 hours without being destroyed by the enzyme, allowing it to work continuously to suppress appetite and aid in weight loss
This distinction becomes particularly relevant when considering the use of SGAs in GLP-1 RA-treated patients, where altered gastric physiology may render such devices vulnerable to failure